NASDAQ$BTSG
Brightspring Health Services Inc · Q1 2025 earnings
Q1 2025 earnings ·
Briefing
BrightSpring Health Services reported Q1 2025, revenue of $2.88B, net income of $29M, diluted EPS of $0.35.
For Q1 2025, BrightSpring Health Services reported revenue of $2.88B, net income of $29M, diluted EPS was $0.35. Management discusses operating trends, capital, and sector risks in the quarterly filing.
- Q1 2025 revenue $2.88B.
- Net income $29M.
- Diluted EPS $0.35.
Headline financials
Revenue & EPS history
Brightspring Health Services Inc · Revenue · Quarterly
$2.88B
Forward guidance
Growth and biotech filers emphasize pipeline, commercial ramp, and cash runway rather than near-term GAAP profitability targets.
Tailwinds
- Product revenue growth or launch momentum.
- Partnership and platform expansion.
- Balance sheet liquidity for R&D.
Headwinds
- Operating losses until scale is reached.
- R&D and SG&A spend ahead of revenue.
- Regulatory and reimbursement risk.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q1 2025
+4.4%
Avg return
Earnings day
+7.8%
Avg return
5 days after
+15.8%
Avg return
30 days after
75%
6 / 8 earnings
Positive
+16.6%
Q1 2025
Best reaction
-8.7%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.6% | +9.9% | +28.5% | |
| Q4 2025 | +3.2% | +4.6% | +5.5% | |
| Q3 2025 | +0.5% | -2.3% | +7.8% | |
| Q2 2025 | -4.9% | -0.7% | +14.7% | |
| Q1 2025 | +16.6% | +28.7% | +33.0% | |
| Q3 2024 | +15.2% | +22.6% | +28.9% | |
| Q2 2024 | -8.7% | -8.1% | +2.6% | |
| Q1 2024 | +3.8% | +7.7% | +5.5% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro